Best Practices ▶ Peer-Reviewed Papers

The Net Chance of a Longer Survival as a Patient-Oriented Measure of Treatment Benefit in Randomized Clinical Trials

  Back

https://uploads-ssl.webflow.com/65dc93ef0a9b2f3705d0635e/6602a79c53f57f5b129c45bc_JAMA%20Oncology.PNG

Read also



Generalized Pairwise Comparisons to Assess Treatment Effects: JACC Review Topic of the Week
Best Practices
Generalized Pairwise Comparisons to Assess Treatment Effects: JACC Review Topic of the Week
READ MORE →
 The tyranny of non-inferiority trials
Best Practices
The tyranny of non-inferiority trials
READ MORE →
 How an Innovative Statistical Methodology Enables More Patient-Centric Design and Analysis of Clinical Trials
Best Practices
How an Innovative Statistical Methodology Enables More Patient-Centric Design and Analysis of Clinical Trials
READ MORE →
 Understanding and Communicating Measures of Treatment Effect on Survival: Can We Do Better?
Best Practices
Understanding and Communicating Measures of Treatment Effect on Survival: Can We Do Better?
READ MORE →